Path: utzoo!utgpu!jarvis.csri.toronto.edu!clyde.concordia.ca!mcgill-vision!bloom-beacon!mintaka!yale!think!samsung!usc!ucla-cs!denbeste@spdcc.com From: denbeste@spdcc.com (Steven Den Beste) Newsgroups: sci.med.aids Subject: Re: AIDS Message-ID: <31599@shemp.CS.UCLA.EDU> Date: 7 Feb 90 01:09:21 GMT References: <31500@shemp.CS.UCLA.EDU> <31537@shemp.CS.UCLA.EDU> Sender: news@CS.UCLA.EDU Reply-To: denbeste@ursa-major.spdcc.com (Steven Den Beste) Organization: S.P. Dyer Computer Consulting, Cambridge MA Lines: 54 Approved: aids@cs.ucla.edu Archive-number: 1673 In article <31537@shemp.CS.UCLA.EDU> bob@ozdaltx.UUCP (bob) writes: >In article <31500@shemp.CS.UCLA.EDU>, Drew.Hamilton@p5.f180.n221.z1.fidonet.org (Drew Hamilton) writes: >> >> >> Also, Can the immune system be taught to battle AIDS (just like chiken pox) >> cause we could just develop an immunity shot to give a small dosage of AIDS to >> the person. >> >It is worth noting that the chicken pox example and other vaccines >differ in another critical way from HIV - they don't attack the immune >system directly. And in some of these vaccinations we are looking at >using a less serious disease to provoke immunity which also works >against a more serious disease which is genetically close. So far >there doesn't appear to be anything like that with AIDS. > The only theoretical basis for a perfectly safe AIDS vaccine appears to require genetic information. The immune system antibody response is not to the genetic information within HIV, but rather to the shell encasing that genetic information. If you can reproduce the proteins (?? sugars?) alone, and inject those into someone, there is no chance that they will get AIDS. Nonetheless, their immune system would go through a recognition/battle response, and thenceforth there would be a residual level of anti-HIV antibodies in their blood. (They'd react as being positive thereafter on the HIV tests available now, which is ironic if they turn out to be immune! How are the insurance companies going to tell the difference between HIV-infected (positive test response) people that they don't want to insure, and HIV-vaccinated (positive test result) people that they really DO want to insure?) Hopefully, what would then occur takes advantage of the relatively high proportion of antibodies within a unit volume of blood as opposed to the number of T4 cells. The virus has no active propulsion system, but relies solely on turbulence to bring it into contact with T4 cells, which it then invades. If there are a million times as many anti-HIV antibodies as T4 cells then the virus is much more likely to touch one of THEM (and stick, deactivating the virus) first. At least, that is the hope. The problem with all this reasoning is that the initial HIV infection appears to cause a quite reasonable anti-body response, so after the first invasion the HIV being re-released into the blood from T4 cells should be getting deactivated immediately. In other words, they should be getting well. They don't, however. I think that there are two reasons that research in this area is continuing: 1. Possibly if there are already antibodies in place when the initial invasion occurs it can be controlled. It may sort of be like stopping a forest fire when it is 1 foot across by throwing a bucket of water on it, instead of waiting until it consumes half the state of Wyoming before you begin fighting. 2. The other reason is desperation. If this doesn't work, then there doesn't appear to be any other way to prevent the disease at the current state of the art. So even though this kind of vaccine doesn't look promising, it's the only game in town. So work continues.